- Home
- BDL vs NTRB Comparison
BDL vs NTRB Comparison
Compare BDL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDL | NTRB |
|---|---|---|
| Founded | 1959 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.4M | 71.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BDL | NTRB |
|---|---|---|
| Price | $28.61 | $4.95 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 616.0 | ★ 23.0K |
| Earning Date | 12-26-2025 | 12-11-2025 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | ★ 41.91 | N/A |
| EPS | ★ 2.32 | N/A |
| Revenue | ★ $201,851,000.00 | $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | $12.31 | ★ N/A |
| Revenue Growth | 8.84 | ★ 12.69 |
| 52 Week Low | $22.61 | $3.72 |
| 52 Week High | $35.98 | $11.78 |
Technical Indicators
Market Signals| Indicator | BDL | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 41.05 | 45.12 |
| Support Level | $27.55 | $4.60 |
| Resistance Level | $30.01 | $5.45 |
| Average True Range (ATR) | 0.19 | 0.37 |
| MACD | -0.24 | 0.10 |
| Stochastic Oscillator | 20.27 | 64.79 |
Price Performance
Historical ComparisonAbout BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.